On-body Injectors Market Report

Europe On-body Injectors Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 17, 2020
  • PAGES：176
  • REPORT CODE：GMM438298
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The On-body Injectors market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe On-body Injectors Market Segmentations:

    By Player:

    • SteadyMed Therapeutics

    • SteadyMed

    • SteadyMed Therapeutics

    • Valeritas

    • Insulet

    • Roche

    • SteadyMed Therapeutics

    • BD Medical

    • Ypsomed

    • ScPharmaceuticals

    • Sensile Medical

    • CeQur

    • Tandem Diabetes Care

    • Enable Injections

    By Type:

    • Electronical Injectors

    • Mechanical Injectors

    • Others

    By End-User:

    • Immuno-oncology

    • Diabetes

    • Cardiovascular Diseases

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of On-body Injectors Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe On-body Injectors Market Size and Growth Rate of Electronical Injectors from 2014 to 2026

    • 1.3.2 Europe On-body Injectors Market Size and Growth Rate of Mechanical Injectors from 2014 to 2026

    • 1.3.3 Europe On-body Injectors Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe On-body Injectors Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • 1.4.2 Europe On-body Injectors Market Size and Growth Rate of Diabetes from 2014 to 2026

    • 1.4.3 Europe On-body Injectors Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • 1.4.4 Europe On-body Injectors Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of On-body Injectors Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of On-body Injectors by Major Types

      • 3.4.1 Market Size and Growth Rate of Electronical Injectors

      • 3.4.2 Market Size and Growth Rate of Mechanical Injectors

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of On-body Injectors Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of On-body Injectors by Major End-Users

      • 4.4.1 Market Size and Growth Rate of On-body Injectors for Immuno-oncology

      • 4.4.2 Market Size and Growth Rate of On-body Injectors for Diabetes

      • 4.4.3 Market Size and Growth Rate of On-body Injectors for Cardiovascular Diseases

      • 4.4.4 Market Size and Growth Rate of On-body Injectors for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe On-body Injectors Production Analysis by Top Regions

    • 5.2 Europe On-body Injectors Consumption Analysis by Top Regions

    • 5.3 Europe On-body Injectors Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.2 UK On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.3 France On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Production, Import, Consumption and Export Analysis

    6 Product Circulation of On-body Injectors Market among Top Countries

    • 6.1 Top 5 Export Countries in On-body Injectors Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in On-body Injectors Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in On-body Injectors Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in On-body Injectors Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in On-body Injectors Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in On-body Injectors Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany On-body Injectors Landscape Analysis

    • 7.1 Germany On-body Injectors Landscape Analysis by Major Types

    • 7.2 Germany On-body Injectors Landscape Analysis by Major End-Users

    8. UK On-body Injectors Landscape Analysis

    • 8.1 UK On-body Injectors Landscape Analysis by Major Types

    • 8.2 UK On-body Injectors Landscape Analysis by Major End-Users

    9. France On-body Injectors Landscape Analysis

    • 9.1 France On-body Injectors Landscape Analysis by Major Types

    • 9.2 France On-body Injectors Landscape Analysis by Major End-Users

    10. Italy On-body Injectors Landscape Analysis

    • 10.1 Italy On-body Injectors Landscape Analysis by Major Types

    • 10.2 Italy On-body Injectors Landscape Analysis by Major End-Users

    11. Spain On-body Injectors Landscape Analysis

    • 11.1 Spain On-body Injectors Landscape Analysis by Major Types

    • 11.2 Spain On-body Injectors Landscape Analysis by Major End-Users

    12. Poland On-body Injectors Landscape Analysis

    • 12.1 Poland On-body Injectors Landscape Analysis by Major Types

    • 12.2 Poland On-body Injectors Landscape Analysis by Major End-Users

    13. Russia On-body Injectors Landscape Analysis

    • 13.1 Russia On-body Injectors Landscape Analysis by Major Types

    • 13.2 Russia On-body Injectors Landscape Analysis by Major End-Users

    14. Switzerland On-body Injectors Landscape Analysis

    • 14.1 Switzerland On-body Injectors Landscape Analysis by Major Types

    • 14.2 Switzerland On-body Injectors Landscape Analysis by Major End-Users

    15. Turkey On-body Injectors Landscape Analysis

    • 15.1 Turkey On-body Injectors Landscape Analysis by Major Types

    • 15.2 Turkey On-body Injectors Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Landscape Analysis by Top Countries

      • 16.3.1 Denmark On-body Injectors Market Volume and Growth Rate

      • 16.3.2 Finland On-body Injectors Market Volume and Growth Rate

      • 16.3.3 Norway On-body Injectors Market Volume and Growth Rate

      • 16.3.4 Sweden On-body Injectors Market Volume and Growth Rate

      • 16.3.6 Iceland On-body Injectors Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Landscape Analysis by Top Countries

      • 17.3.1 Belgium On-body Injectors Market Volume and Growth Rate

      • 17.3.2 Netherlands On-body Injectors Market Volume and Growth Rate

      • 17.3.3 Luxembourg On-body Injectors Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Landscape Analysis by Top Countries

      • 18.3.1 Estonia On-body Injectors Market Volume and Growth Rate

      • 18.3.2 Latvia On-body Injectors Market Volume and Growth Rate

      • 18.3.3 Lithuania On-body Injectors Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 SteadyMed Therapeutics

      • 19.1.1 SteadyMed Therapeutics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 SteadyMed

      • 19.2.1 SteadyMed Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 SteadyMed Therapeutics

      • 19.3.1 SteadyMed Therapeutics Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Valeritas

      • 19.4.1 Valeritas Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Insulet

      • 19.5.1 Insulet Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Roche

      • 19.6.1 Roche Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 SteadyMed Therapeutics

      • 19.7.1 SteadyMed Therapeutics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 BD Medical

      • 19.8.1 BD Medical Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Ypsomed

      • 19.9.1 Ypsomed Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 ScPharmaceuticals

      • 19.10.1 ScPharmaceuticals Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Sensile Medical

      • 19.11.1 Sensile Medical Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 CeQur

      • 19.12.1 CeQur Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Tandem Diabetes Care

      • 19.13.1 Tandem Diabetes Care Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Enable Injections

      • 19.14.1 Enable Injections Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 94 Figures and 142 Tables)

    • Figure Product Picture

    • Figure Europe On-body Injectors Market Size and Growth Rate of Electronical Injectors from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Mechanical Injectors from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Europe On-body Injectors Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure UK On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure France On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Italy On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Spain On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Poland On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Russia On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Canada On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Finland On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Norway On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania On-body Injectors Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of On-body Injectors Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of On-body Injectors

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of On-body Injectors by Different Types from 2014 to 2026

    • Table Consumption Share of On-body Injectors by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Electronical Injectors

    • Figure Market Size and Growth Rate of Mechanical Injectors

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of On-body Injectors by Different End-Users from 2014 to 2026

    • Table Consumption Share of On-body Injectors by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Immuno-oncology

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Europe On-body Injectors Production by Major Regions

    • Table Europe On-body Injectors Production Share by Major Regions

    • Figure Europe On-body Injectors Production Share by Major Countries and Regions in 2014

    • Table Europe On-body Injectors Consumption by Major Regions

    • Table Europe On-body Injectors Consumption Share by Major Regions

    • Table Germany On-body Injectors Production, Import, Consumption and Export Analysis

    • Table UK On-body Injectors Production, Import, Consumption and Export Analysis

    • Table France On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Italy On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Spain On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Poland On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Russia On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Switzerland On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Turkey On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in On-body Injectors Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in On-body Injectors Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in On-body Injectors Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in On-body Injectors Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany On-body Injectors Consumption by Types from 2014 to 2026

    • Table Germany On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Germany On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Germany On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table UK On-body Injectors Consumption by Types from 2014 to 2026

    • Table UK On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table UK On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table UK On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table France On-body Injectors Consumption by Types from 2014 to 2026

    • Table France On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table France On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table France On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Italy On-body Injectors Consumption by Types from 2014 to 2026

    • Table Italy On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Italy On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Italy On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Spain On-body Injectors Consumption by Types from 2014 to 2026

    • Table Spain On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Spain On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Spain On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Poland On-body Injectors Consumption by Types from 2014 to 2026

    • Table Poland On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Poland On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Poland On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Russia On-body Injectors Consumption by Types from 2014 to 2026

    • Table Russia On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Russia On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Russia On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland On-body Injectors Consumption by Types from 2014 to 2026

    • Table Switzerland On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Switzerland On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Switzerland On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Turkey On-body Injectors Consumption by Types from 2014 to 2026

    • Table Turkey On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Turkey On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Turkey On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) On-body Injectors Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) On-body Injectors Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) On-body Injectors Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries On-body Injectors Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of SteadyMed Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SteadyMed Therapeutics

    • Figure Sales and Growth Rate Analysis of SteadyMed Therapeutics

    • Figure Revenue and Market Share Analysis of SteadyMed Therapeutics

    • Table Product and Service Introduction of SteadyMed Therapeutics

    • Table Company Profile and Development Status of SteadyMed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SteadyMed

    • Figure Sales and Growth Rate Analysis of SteadyMed

    • Figure Revenue and Market Share Analysis of SteadyMed

    • Table Product and Service Introduction of SteadyMed

    • Table Company Profile and Development Status of SteadyMed Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SteadyMed Therapeutics

    • Figure Sales and Growth Rate Analysis of SteadyMed Therapeutics

    • Figure Revenue and Market Share Analysis of SteadyMed Therapeutics

    • Table Product and Service Introduction of SteadyMed Therapeutics

    • Table Company Profile and Development Status of Valeritas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeritas

    • Figure Sales and Growth Rate Analysis of Valeritas

    • Figure Revenue and Market Share Analysis of Valeritas

    • Table Product and Service Introduction of Valeritas

    • Table Company Profile and Development Status of Insulet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insulet

    • Figure Sales and Growth Rate Analysis of Insulet

    • Figure Revenue and Market Share Analysis of Insulet

    • Table Product and Service Introduction of Insulet

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of SteadyMed Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SteadyMed Therapeutics

    • Figure Sales and Growth Rate Analysis of SteadyMed Therapeutics

    • Figure Revenue and Market Share Analysis of SteadyMed Therapeutics

    • Table Product and Service Introduction of SteadyMed Therapeutics

    • Table Company Profile and Development Status of BD Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD Medical

    • Figure Sales and Growth Rate Analysis of BD Medical

    • Figure Revenue and Market Share Analysis of BD Medical

    • Table Product and Service Introduction of BD Medical

    • Table Company Profile and Development Status of Ypsomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ypsomed

    • Figure Sales and Growth Rate Analysis of Ypsomed

    • Figure Revenue and Market Share Analysis of Ypsomed

    • Table Product and Service Introduction of Ypsomed

    • Table Company Profile and Development Status of ScPharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ScPharmaceuticals

    • Figure Sales and Growth Rate Analysis of ScPharmaceuticals

    • Figure Revenue and Market Share Analysis of ScPharmaceuticals

    • Table Product and Service Introduction of ScPharmaceuticals

    • Table Company Profile and Development Status of Sensile Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sensile Medical

    • Figure Sales and Growth Rate Analysis of Sensile Medical

    • Figure Revenue and Market Share Analysis of Sensile Medical

    • Table Product and Service Introduction of Sensile Medical

    • Table Company Profile and Development Status of CeQur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CeQur

    • Figure Sales and Growth Rate Analysis of CeQur

    • Figure Revenue and Market Share Analysis of CeQur

    • Table Product and Service Introduction of CeQur

    • Table Company Profile and Development Status of Tandem Diabetes Care

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tandem Diabetes Care

    • Figure Sales and Growth Rate Analysis of Tandem Diabetes Care

    • Figure Revenue and Market Share Analysis of Tandem Diabetes Care

    • Table Product and Service Introduction of Tandem Diabetes Care

    • Table Company Profile and Development Status of Enable Injections

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enable Injections

    • Figure Sales and Growth Rate Analysis of Enable Injections

    • Figure Revenue and Market Share Analysis of Enable Injections

    • Table Product and Service Introduction of Enable Injections

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US